Bruton’s tyrosine kinase (BTK) inhibitors

Bruton’s tyrosine kinase (BTK) inhibitors are a type of medication used primarily to treat certain blood cancers, like chronic lymphocytic leukemia and mantle cell lymphoma. BTK is a protein that helps cancer cells grow and survive. By blocking this protein, BTK inhibitors can slow down or stop the growth of these cancer cells, leading to better outcomes for patients. These drugs offer a targeted approach to therapy, often with different side effects compared to traditional chemotherapy, making them an important option in cancer treatment.